CELG

Celgene Corporation News Headlines

$92
*  
3.88
4.4%
Get CELG Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
PowerShares Dynamic Pharmaceuticals ETF: Big Pharma Looks Abroad to Continue Its Run
3/11/2013 11:45:22 AM - SeekingAlpha


Today's Market News To Trade On: 5 Stocks Moving On News
3/11/2013 9:57:00 AM - Seeking Alpha


Looking Back To Alternative Cancer Therapies
3/11/2013 7:18:00 AM - Seeking Alpha


Amgen And The Biosimilar Threat: Lessons From Affymax
3/8/2013 10:43:00 AM - Seeking Alpha


Onyx Pharmaceuticals Is Moving Beyond The Threat Of Celgene's Pomalyst
3/7/2013 10:15:00 AM - Seeking Alpha


Cramer's Mad Money - Stocks That Are Safe At Any Speed (3/6/13)
3/7/2013 5:25:00 AM - Seeking Alpha


2 Biotech Superstars For 2013
3/5/2013 7:29:00 PM - Seeking Alpha


Pluristem & UTHR Progress with PLX-PAD - Analyst Blog
3/4/2013 6:25:01 PM - Zacks.com


Celgene's Apremilast Encourages - Analyst Blog
3/4/2013 2:30:01 PM - Zacks.com


Celgene: Phenomenal Guidance For This Bio Stock
3/4/2013 7:38:00 AM - Seeking Alpha


Immunomedics Has A Cheap, Deep And Recently Capitalized Pipeline
3/1/2013 12:45:00 PM - Seeking Alpha


3 Stocks With Strong Buybacks And How To Invest: TJX, Texas Instruments, And Celgene
3/1/2013 11:42:00 AM - Seeking Alpha


3 Solid, Low Beta Biotechnology Stocks To Buy On Dip
2/26/2013 2:38:00 PM - Seeking Alpha


Special Protocol Assessments: The Case Studies
2/22/2013 2:31:00 PM - Seeking Alpha


A Biotech Winner For 2013
2/21/2013 8:25:00 PM - Seeking Alpha


Celgene Plans $600M Share Buyback - Analyst Blog
2/21/2013 5:50:01 PM - Zacks.com


Don't Tune Out; Pharmacyclics' Move Higher Isn't Over Yet
2/21/2013 8:58:00 AM - Seeking Alpha


Cyclacel Pharma: Undervalued With Its Potential Blockbuster Drug
2/21/2013 7:50:00 AM - Seeking Alpha


Upcoming Catalysts For These BioPharmas Provide Potential Upside
2/20/2013 8:05:00 AM - Seeking Alpha


Does Celgene Have More Room To Run In 2013?
2/19/2013 5:20:00 PM - Seeking Alpha


Stocks Could Rise For Companies Investing In Immunotherapy Treatments
2/18/2013 2:16:00 PM - Seeking Alpha


Multiple Myeloma And Different Treatment Approaches
2/17/2013 4:05:00 AM - Seeking Alpha


China Biotech In Review: Amgen To Build China Presence With Partnerships / M&A
2/17/2013 1:31:00 AM - Seeking Alpha


Celgene And The Race To Cure Multiple Myeloma
2/15/2013 4:31:00 PM - Seeking Alpha


ImmunoGen Progresses with IMGN901 - Analyst Blog
2/14/2013 6:44:51 PM - Zacks.com